Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: University of Virginia
Condition: Lung Cancer
NCT00114192
Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Completed No Results Found Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.